We audited the marketing at Science
Clinical-stage medtech restoring vision, cognition, and mobility
This page was built using the same AI infrastructure we deploy for clients.
Month-to-month. Cancel anytime.
Science Foundry positioning underexposed. B2B2C component/infrastructure play lacks dedicated visibility strategy vs. core clinical programs
10.5K LinkedIn followers for $407M funded medtech suggests minimal founder/leadership visibility in neuroscience and medical device communities
Limited content on clinical trial progress, device validation milestones, or regulatory pathway updates that drive investor and clinician credibility
AI-Forward Companies Trust MarketerHire
Plaid
MasterClass
Constant Contact
Netflix
Noom
TinuitiScience's Leadership
We mapped your current team to understand where MH-1 fits in.
MH-1 doesn't replace your team. It becomes your marketing team: dedicated humans + AI agents running execution at scale while you focus on product.
Here's Where You Stand
Well-funded clinical-stage company with established market position but underutilizing thought leadership and B2B infrastructure narrative
Domain authority exists but clinical evidence pages and device specification content lack depth. Competitors rank for medical device + AI queries
MH-1: SEO agents build regulatory pathway and clinical outcome landing pages targeting neurosurgeon and ophthalmologist search intent
Minimal presence in LLM responses for vision restoration, neural interfaces, or mobility devices. Science Foundry completely absent from AI training data mentions
MH-1: AEO agents inject clinical data, device specifications, and Science Foundry infrastructure into LLM context through structured content and citation placement
No visible paid campaigns targeting clinicians, hospital procurement teams, or biotech founders seeking component suppliers via Science Foundry
MH-1: Paid agents run LinkedIn and Google ads targeting neurosurgeons, ophthalmologists, and medtech founders with clinical validation messaging and Foundry partnership case studies
Founder presence on platforms exists but limited narrative around clinical breakthroughs, regulatory milestones, or Foundry partnership wins in medical device ecosystem
MH-1: Content agents produce monthly clinical progress updates, device validation case studies, and thought leadership on FDA pathways for neural/vision restoration devices
No visible nurture campaigns for hospital systems evaluating vision restoration, clinician communities in mobility/cognition, or biotech teams interested in Science Foundry components
MH-1: Lifecycle agents segment prospects by clinical application and Foundry interest, running automated email sequences on clinical trial phases and component availability
Top Growth Opportunities
Vertically integrated infrastructure play is massive differentiation vs. pure clinical competitors but buried. Biotech founders actively search for validated medtech components
Create dedicated Foundry landing page, run targeted ads to biotech founder networks, build partnership case studies highlighting component adoption and device acceleration
Series C funding ($230M) and 31.9% YoY growth signal rapid advancement in vision, cognition, mobility programs. Clinicians and investors monitor trial enrollment and outcomes closely
Monthly clinical milestone content, neurosurgeon/ophthalmologist outbound sequences around trial data, LinkedIn updates from medical director Frank Brodie on PRIMA progress
FDA clearance, breakthrough device status, and clinical evidence are decision drivers for hospital adoption and investor confidence. Competitors lack clear regulatory narrative
Build comprehensive regulatory timeline content, produce podcasts with medical leadership on FDA strategy, run paid campaigns targeting hospital procurement on cleared devices
3 Humans + 7 AI Agents
A dedicated marketing team built specifically for Science. The humans handle strategy and judgment. The AI agents handle execution at scale.
Human Experts
Owns Science's growth roadmap. Pipeline strategy, account expansion playbooks, board-ready reporting. Translates AI insights into revenue.
Runs paid acquisition across LinkedIn and Google. Manages creative testing, budget allocation, and pipeline attribution.
Builds thought leadership on LinkedIn. Creates long-form content targeting your ICP. Manages the content-to-pipeline engine.
AI Agents
Monitors AI citation visibility across 6 LLMs weekly. Builds content targeting category queries to increase Science's presence in AI-generated answers.
Produces LinkedIn ad variants targeting your ICP. Tests headlines, visuals, and offers at 10x the speed of manual production.
Builds lifecycle sequences: onboarding, expansion triggers, champion nurture, and re-engagement for dormant accounts.
Founder thought leadership. Builds the narrative that drives enterprise inbound from senior decision-makers.
Tracks competitors. Monitors positioning changes, ad spend, content strategy. Informs your counter-positioning.
Attribution by channel, pipeline velocity, budget waste detection. Weekly synthesis reports with AI-generated recommendations.
Weekly market intelligence digest curated from Science's industry signals. Positions you as the intelligence layer. Drives inbound pipeline from subscribers.
Active Workflows
Here's what the MH-1 system would be doing for Science from week 1.
AEO agent monitors LLM responses for queries about neural interfaces, vision restoration devices, and medtech infrastructure. Injects Science Corporation clinical data and Foundry component specs into training context daily
Founder outreach agent builds LinkedIn cadence for Richard Socarides and Frank Brodie targeting neurosurgeons, hospital innovation teams, and biotech founders seeking clinical validation partnerships
Paid acquisition agent runs LinkedIn campaigns to hospital procurement, neuroscientist communities, and biotech founders. Tests messaging around clinical breakthroughs, device clearances, and Foundry partnership ROI
Lifecycle agent segments prospects by clinical interest (vision vs. cognition vs. mobility), Foundry component need, and buyer stage. Delivers automated clinical trial updates and partnership case studies
Competitive watch agent monitors Solio, Sherlock, Elements Science, and Krystal Bio for clinical announcements, fundraising, regulatory wins. Surfaces opportunities to differentiate on Foundry ecosystem
Pipeline intelligence agent tracks hospital system procurement cycles, biotech founder networks, and neuroscience conference attendees. Identifies accounts with high Science Foundry component fit and trial interest
Traditional Marketing vs. MH-1
Traditional Approach
MH-1 System
Audit. Sprint. Optimize.
3 phases. Real output every 2 weeks. You see results, not decks.
AI Audit + Growth Roadmap
Full diagnostic of Science's marketing infrastructure: SEO, AEO visibility, paid, content, lifecycle. Prioritized roadmap tied to pipeline metrics. Delivered in 7 days.
Sprint-Based Execution
2-week sprint cycles. Real campaigns, not presentations. Each sprint ships measurable output across your priority channels.
Compounding Intelligence
AI agents monitor your channels 24/7. They catch budget waste, detect creative fatigue, track AI citation changes, and run A/B experiments autonomously. Week 12 is measurably better than week 1.
AI Marketing Operating System
3 elite humans + AI agents operating your growth system
Output multiplier: ~10x output at a fraction of the cost. The system gets smarter every week.
Month-to-month. Cancel anytime.
Common Questions
How does MH-1 differ from a marketing agency?
MH-1 pairs 3 elite human marketers with 7 AI agents. The humans handle strategy, creative direction, and judgment calls. The AI agents handle execution at scale: generating ad variants, monitoring competitors, building email sequences, tracking citations across LLMs, running A/B experiments autonomously. You get the quality of a senior marketing team with the output volume of a 15-person department.
What kind of results can we expect in the first 90 days?
First 90 days focus on AEO penetration for Foundry positioning and clinical milestone visibility. MH-1 maps LLM queries across neuroscience, medtech, and AI communities. Agents launch SEO content on regulatory pathways, paid campaigns to hospital procurement and biotech networks, and LinkedIn thought leadership from medical leadership. By day 90 expect increased demo requests from biotech founders and hospital innovation teams evaluating Science's devices
How do potential Foundry partners discover Science's component infrastructure
Most biotech founders searching for validated neural interface or vision restoration components never see Science Corporation in LLM responses because the Foundry narrative isn't embedded in AI training data. MH-1's AEO agents ensure Science appears when biotech teams ask about medtech component suppliers, clinical validation paths, or regulatory-cleared platforms
Can we cancel anytime?
Yes. MH-1 is month-to-month with no long-term contracts. We earn your business every sprint. That said, compounding effects kick in around month 3 as the AI agents accumulate data and the system learns what works for Science specifically.
How is this page personalized for Science?
This page was researched, audited, and generated using the same AI infrastructure we deploy for clients. The channel scores, team mapping, growth opportunities, and recommended agents are all based on real analysis of Science's current marketing. This is a live demo of MH-1's capabilities.
Scale clinical validation and Foundry adoption with autonomous medtech marketing
The system gets smarter every cycle. Let's talk about building it for Science.
Book a Strategy CallMonth-to-month. Cancel anytime.